Disruption of growth factor receptor-binding protein 10 in the pancreas enhances β-cell proliferation and protects mice from streptozotocin-induced β-cell apoptosis

Jingjing Zhang, Ning Zhang, Meilian Liu, Xiuling Li, Lijun Zhou, Wei Huang, Zhipeng Xu, Jing Liu, Nicolas Musi, Ralph A. DeFronzo, John M. Cunningham, Zhiguang Zhou, Xinyun Lu, Feng Liu

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Defects in insulin secretion and reduction in β-cell mass are associated with type 2 diabetes in humans, and understanding the basis for these dysfunctions may reveal strategies for diabetes therapy. In this study, we show that pancreas-specific knockout of growth factor receptor-binding protein 10 (Grb10), which is highly expressed in pancreas and islets, leads to elevated insulin/ IGF-1 signaling in islets, enhanced β-cell mass and insulin content, and increased insulin secretion in mice. Pancreas-specific disruption of Grb10 expression also improved glucose tolerance in mice fed with a high-fat diet and protected mice from streptozotocin-induced β-cell apoptosis and body weight loss. Our study has identified Grb10 as an important regulator of β-cell proliferation and demonstrated that reducing the expression level of Grb10 could provide a novel means to increase β-cell mass and reduce β-cell apoptosis. This is critical for effective therapeutic treatment of both type 1 and 2 diabetes.

Original languageEnglish (US)
Pages (from-to)3189-3198
Number of pages10
JournalDiabetes
Volume61
Issue number12
DOIs
StatePublished - Dec 1 2012
Externally publishedYes

Fingerprint

Growth Factor Receptors
Streptozocin
Pancreas
Carrier Proteins
Cell Proliferation
Insulin
Apoptosis
Type 2 Diabetes Mellitus
High Fat Diet
Type 1 Diabetes Mellitus
Insulin-Like Growth Factor I
Islets of Langerhans
Weight Loss
Body Weight
Glucose
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Disruption of growth factor receptor-binding protein 10 in the pancreas enhances β-cell proliferation and protects mice from streptozotocin-induced β-cell apoptosis. / Zhang, Jingjing; Zhang, Ning; Liu, Meilian; Li, Xiuling; Zhou, Lijun; Huang, Wei; Xu, Zhipeng; Liu, Jing; Musi, Nicolas; DeFronzo, Ralph A.; Cunningham, John M.; Zhou, Zhiguang; Lu, Xinyun; Liu, Feng.

In: Diabetes, Vol. 61, No. 12, 01.12.2012, p. 3189-3198.

Research output: Contribution to journalArticle

Zhang, J, Zhang, N, Liu, M, Li, X, Zhou, L, Huang, W, Xu, Z, Liu, J, Musi, N, DeFronzo, RA, Cunningham, JM, Zhou, Z, Lu, X & Liu, F 2012, 'Disruption of growth factor receptor-binding protein 10 in the pancreas enhances β-cell proliferation and protects mice from streptozotocin-induced β-cell apoptosis', Diabetes, vol. 61, no. 12, pp. 3189-3198. https://doi.org/10.2337/db12-0249
Zhang, Jingjing ; Zhang, Ning ; Liu, Meilian ; Li, Xiuling ; Zhou, Lijun ; Huang, Wei ; Xu, Zhipeng ; Liu, Jing ; Musi, Nicolas ; DeFronzo, Ralph A. ; Cunningham, John M. ; Zhou, Zhiguang ; Lu, Xinyun ; Liu, Feng. / Disruption of growth factor receptor-binding protein 10 in the pancreas enhances β-cell proliferation and protects mice from streptozotocin-induced β-cell apoptosis. In: Diabetes. 2012 ; Vol. 61, No. 12. pp. 3189-3198.
@article{9f3a7d86c1e14df2b2887fa6fca5532f,
title = "Disruption of growth factor receptor-binding protein 10 in the pancreas enhances β-cell proliferation and protects mice from streptozotocin-induced β-cell apoptosis",
abstract = "Defects in insulin secretion and reduction in β-cell mass are associated with type 2 diabetes in humans, and understanding the basis for these dysfunctions may reveal strategies for diabetes therapy. In this study, we show that pancreas-specific knockout of growth factor receptor-binding protein 10 (Grb10), which is highly expressed in pancreas and islets, leads to elevated insulin/ IGF-1 signaling in islets, enhanced β-cell mass and insulin content, and increased insulin secretion in mice. Pancreas-specific disruption of Grb10 expression also improved glucose tolerance in mice fed with a high-fat diet and protected mice from streptozotocin-induced β-cell apoptosis and body weight loss. Our study has identified Grb10 as an important regulator of β-cell proliferation and demonstrated that reducing the expression level of Grb10 could provide a novel means to increase β-cell mass and reduce β-cell apoptosis. This is critical for effective therapeutic treatment of both type 1 and 2 diabetes.",
author = "Jingjing Zhang and Ning Zhang and Meilian Liu and Xiuling Li and Lijun Zhou and Wei Huang and Zhipeng Xu and Jing Liu and Nicolas Musi and DeFronzo, {Ralph A.} and Cunningham, {John M.} and Zhiguang Zhou and Xinyun Lu and Feng Liu",
year = "2012",
month = "12",
day = "1",
doi = "10.2337/db12-0249",
language = "English (US)",
volume = "61",
pages = "3189--3198",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "12",

}

TY - JOUR

T1 - Disruption of growth factor receptor-binding protein 10 in the pancreas enhances β-cell proliferation and protects mice from streptozotocin-induced β-cell apoptosis

AU - Zhang, Jingjing

AU - Zhang, Ning

AU - Liu, Meilian

AU - Li, Xiuling

AU - Zhou, Lijun

AU - Huang, Wei

AU - Xu, Zhipeng

AU - Liu, Jing

AU - Musi, Nicolas

AU - DeFronzo, Ralph A.

AU - Cunningham, John M.

AU - Zhou, Zhiguang

AU - Lu, Xinyun

AU - Liu, Feng

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Defects in insulin secretion and reduction in β-cell mass are associated with type 2 diabetes in humans, and understanding the basis for these dysfunctions may reveal strategies for diabetes therapy. In this study, we show that pancreas-specific knockout of growth factor receptor-binding protein 10 (Grb10), which is highly expressed in pancreas and islets, leads to elevated insulin/ IGF-1 signaling in islets, enhanced β-cell mass and insulin content, and increased insulin secretion in mice. Pancreas-specific disruption of Grb10 expression also improved glucose tolerance in mice fed with a high-fat diet and protected mice from streptozotocin-induced β-cell apoptosis and body weight loss. Our study has identified Grb10 as an important regulator of β-cell proliferation and demonstrated that reducing the expression level of Grb10 could provide a novel means to increase β-cell mass and reduce β-cell apoptosis. This is critical for effective therapeutic treatment of both type 1 and 2 diabetes.

AB - Defects in insulin secretion and reduction in β-cell mass are associated with type 2 diabetes in humans, and understanding the basis for these dysfunctions may reveal strategies for diabetes therapy. In this study, we show that pancreas-specific knockout of growth factor receptor-binding protein 10 (Grb10), which is highly expressed in pancreas and islets, leads to elevated insulin/ IGF-1 signaling in islets, enhanced β-cell mass and insulin content, and increased insulin secretion in mice. Pancreas-specific disruption of Grb10 expression also improved glucose tolerance in mice fed with a high-fat diet and protected mice from streptozotocin-induced β-cell apoptosis and body weight loss. Our study has identified Grb10 as an important regulator of β-cell proliferation and demonstrated that reducing the expression level of Grb10 could provide a novel means to increase β-cell mass and reduce β-cell apoptosis. This is critical for effective therapeutic treatment of both type 1 and 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84870382204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870382204&partnerID=8YFLogxK

U2 - 10.2337/db12-0249

DO - 10.2337/db12-0249

M3 - Article

C2 - 22923474

AN - SCOPUS:84870382204

VL - 61

SP - 3189

EP - 3198

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 12

ER -